Oxford Nanopore Technologies Ltd (ONT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.040x

Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has a cash flow conversion efficiency ratio of -0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-18.60 Million ≈ $-2.26K USD) by net assets (GBX463.30 Million ≈ $56.37K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oxford Nanopore Technologies Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Oxford Nanopore Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ONT liabilities breakdown for a breakdown of total debt and financial obligations.

Oxford Nanopore Technologies Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
LZ Technology Holdings Limited Class B Ordinary Shares
NASDAQ:LZMH
N/A
Soditech SA
PA:SEC
0.053x
Schulte-Schlagbaum AG
DU:SSS
N/A
SSH Group Ltd
AU:SSH
0.196x
CSH Alliance Bhd
KLSE:7165
0.085x
Temple Bar Investment Trust
LSE:TMPL
0.018x
Nusa Palapa Gemilang PT Tbk
JK:NPGF
0.084x
Scienture Holdings, Inc.
NASDAQ:SCNX
0.000x

Annual Cash Flow Conversion Efficiency for Oxford Nanopore Technologies Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Oxford Nanopore Technologies Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see ONT market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX463.30 Million
≈ $56.37K
GBX-62.80 Million
≈ $-7.64K
-0.136x +27.67%
2024-12-31 GBX586.34 Million
≈ $71.34K
GBX-109.89 Million
≈ $-13.37K
-0.187x +12.12%
2023-12-31 GBX643.85 Million
≈ $78.34K
GBX-137.30 Million
≈ $-16.71K
-0.213x -199.47%
2022-12-31 GBX693.56 Million
≈ $84.39K
GBX-49.39 Million
≈ $-6.01K
-0.071x +6.87%
2021-12-31 GBX703.98 Million
≈ $85.65K
GBX-53.83 Million
≈ $-6.55K
-0.076x +77.72%
2020-12-31 GBX185.93 Million
≈ $22.62K
GBX-63.81 Million
≈ $-7.76K
-0.343x +22.79%
2019-12-31 GBX109.53 Million
≈ $13.33K
GBX-48.68 Million
≈ $-5.92K
-0.444x -14.41%
2018-12-31 GBX142.89 Million
≈ $17.39K
GBX-55.51 Million
≈ $-6.75K
-0.388x +45.20%
2017-12-31 GBX93.58 Million
≈ $11.39K
GBX-66.34 Million
≈ $-8.07K
-0.709x -101.08%
2016-12-31 GBX145.24 Million
≈ $17.67K
GBX-51.21 Million
≈ $-6.23K
-0.353x -6.91%
2015-12-31 GBX100.48 Million
≈ $12.23K
GBX-33.14 Million
≈ $-4.03K
-0.330x +35.73%
2014-12-31 GBX66.02 Million
≈ $8.03K
GBX-33.88 Million
≈ $-4.12K
-0.513x -45.03%
2013-12-31 GBX65.77 Million
≈ $8.00K
GBX-23.27 Million
≈ $-2.83K
-0.354x +16.95%
2012-12-31 GBX49.94 Million
≈ $6.08K
GBX-21.27 Million
≈ $-2.59K
-0.426x --

About Oxford Nanopore Technologies Ltd

LSE:ONT UK Biotechnology
Market Cap
$13.88 Million
GBX114.05 Billion GBX
Market Cap Rank
#26053 Global
#296 in UK
Share Price
GBX117.90
Change (1 day)
+4.89%
52-Week Range
GBX104.50 - GBX219.00
All Time High
GBX716.00
About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hard… Read more